P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”

Detalles Bibliográficos
Autores principales: Mele, G, Cascavilla, N, Di Renzo, N, Guarini, A, Mazza, P, Melillo, L, Pavone, V, Tarantini, G, Curci, P, Falcone, AP, Germano, C, Mele, A, Palazzo, G, Palumbo, G, Reddiconto, G, Rossini, B, Specchia, G, Musto, P, Pastore, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Poster
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011765/
http://dx.doi.org/10.1097/01.HS9.0000829644.33207.9c
_version_ 1784687690238656512
author Mele, G
Cascavilla, N
Di Renzo, N
Guarini, A
Mazza, P
Melillo, L
Pavone, V
Tarantini, G
Curci, P
Falcone, AP
Germano, C
Mele, A
Palazzo, G
Palumbo, G
Reddiconto, G
Rossini, B
Specchia, G
Musto, P
Pastore, D
author_facet Mele, G
Cascavilla, N
Di Renzo, N
Guarini, A
Mazza, P
Melillo, L
Pavone, V
Tarantini, G
Curci, P
Falcone, AP
Germano, C
Mele, A
Palazzo, G
Palumbo, G
Reddiconto, G
Rossini, B
Specchia, G
Musto, P
Pastore, D
author_sort Mele, G
collection PubMed
description
format Online
Article
Text
id pubmed-9011765
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-90117652022-04-18 P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE” Mele, G Cascavilla, N Di Renzo, N Guarini, A Mazza, P Melillo, L Pavone, V Tarantini, G Curci, P Falcone, AP Germano, C Mele, A Palazzo, G Palumbo, G Reddiconto, G Rossini, B Specchia, G Musto, P Pastore, D Hemasphere Poster Lippincott Williams & Wilkins 2022-04-05 /pmc/articles/PMC9011765/ http://dx.doi.org/10.1097/01.HS9.0000829644.33207.9c Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Poster
Mele, G
Cascavilla, N
Di Renzo, N
Guarini, A
Mazza, P
Melillo, L
Pavone, V
Tarantini, G
Curci, P
Falcone, AP
Germano, C
Mele, A
Palazzo, G
Palumbo, G
Reddiconto, G
Rossini, B
Specchia, G
Musto, P
Pastore, D
P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”
title P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”
title_full P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”
title_fullStr P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”
title_full_unstemmed P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”
title_short P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE”
title_sort p18: daratumumab (d) plus bortezomib (v) and dexamethasone (d) as salvage therapy for patients with refractory/relapsed multiple myeloma (rrmm): initial follow-up of an italian multicenter retrospective clinical experience by “rete ematologica pugliese”
topic Poster
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011765/
http://dx.doi.org/10.1097/01.HS9.0000829644.33207.9c
work_keys_str_mv AT meleg p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT cascavillan p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT direnzon p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT guarinia p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT mazzap p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT melillol p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT pavonev p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT tarantinig p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT curcip p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT falconeap p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT germanoc p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT melea p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT palazzog p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT palumbog p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT reddicontog p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT rossinib p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT specchiag p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT mustop p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese
AT pastored p18daratumumabdplusbortezomibvanddexamethasonedassalvagetherapyforpatientswithrefractoryrelapsedmultiplemyelomarrmminitialfollowupofanitalianmulticenterretrospectiveclinicalexperiencebyreteematologicapugliese

Ejemplares similares